Fecal microbial transplantation and fiber supplementation in subjects with obesity and metabolic syndrome: a randomized, placebo-controlled, double blinded trial

肥胖和代谢综合征受试者的粪便微生物移植和纤维补充：一项随机、安慰剂对照、双盲试验

• 批准号: 416975
• 负责人: Mocanu Valentin
• 金额: $ 7.65万
• 依托单位: University of Alberta
• 依托单位国家: 加拿大
• 项目类别: Studentship Programs
• 财政年份: 2019
• 资助国家: 加拿大
• 起止时间: 2019-11-01 至 2022-11-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=416975&lang=en
• 关键词: Diabetes; Fecal Transplant; Fiber; Metabolic Syndrome; Metbolomics; Microbiome; Obesity

This study is looking at the safety and effectiveness of stool transplant, also known as Fecal Microbiota Transplantation (FMT) and fiber supplementation in obesity and metabolic syndrome. Obesity is one of the greatest health epidemics of the 21st cent

这项研究着眼于粪便移植的安全性和有效性，也被称为粪便微生物移植(FMT)和纤维补充剂治疗肥胖和代谢综合征。 肥胖是21世纪最严重的健康流行病之一。